CEACAM5 and non-small cell lung carcinoma: Another study demonstrated that a high baseline CEA level (> 10 ng/mL) was associated with poor OS and PFS in stage IIIB/IV NSCLC patients with EGFR mutations, yet this association was not explored in the EGFR‐wild cohort [33].